OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Allergy and Clinical Immunology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
The pathogenetic role of Th17 immune response in atopic dermatitis	53
What molecular allergy teaches us about genetics and epidemiology of allergies	31
The use of environmental exposure chambers in studies related to ocular surface effects	27
Economic burden of drug-induced anaphylaxis: what can we do better?	23
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	22
Consequences of severe asthma exacerbations	21
Is immunotherapy safe for treatment of severe asthma	20
Liver disease in primary antibody deficiencies	19
Dietary strategies for the prevention of asthma in children	18
Anaphylaxis due to antiallergic and antiasthmatic biologics	18
Pulmonary function testing for the diagnosis of asthma in preschool children	17
Cow's milk allergy	17
E-cigarettes and asthma in adolescents	17
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	17
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	16
Update on occupational allergy, including asthma, to soluble platinum salts	16
Atopic manifestations of inborn errors of immunity	15
Innate and adaptive immunity in allergic airway disease	15
Mast cell conditions and drug allergy: when to suspect and how to manage	14
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	14
Editorial introductions	12
New approaches in childhood asthma treatment	12
Editorial introductions	12
Perioperative anaphylaxis: when the allergological work-up goes negative	12
Real-world evidence of allergen immunotherapy	12

Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	12
Transition of care in inborn errors of immunity	12
Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	12
Ocular involvement in allergic drug reactions	12
Drug allergy desensitization is not a unique recipe	11
Biological therapies, asthma and coronavirus disease 2019	11
Nanoparticles in allergen immunotherapy	11
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	11
Editorial introductions	10
Editorial introductions	10
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	10
A review of food allergy-related costs with consideration to clinical and demographic factors	10
Editorial introductions	10
An immunologist's perspective on anti-COVID-19 vaccines	10
Updates in diagnosis and management of paediatric mastocytosis	10
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	10
Editorial: Advances in drug hypersensitivity reactions	9
Basophil activation test in food allergy: is it ready for real-time?	9
Health disparities in allergic diseases	9
Occupational causes of chronic obstructive pulmonary disease: an update	9
Clinical remission in severe asthma: lights and shadows on an ambitious goal	9
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	9
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	8
Updates in school-based asthma management	8
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	8
Evaluating the glucagon-like peptide-1 receptor in managing asthma	8
Management and treatment of perioperative hypersensitivity	8
Atopic dermatitis endotypes: knowledge for personalized medicine	8
Food-labeling issues for severe food-allergic consumers	8
Precision allergy molecular diagnosis applications in food allergy	7
The complexity in DNA methylation analysis of allergic diseases	7
Biomarkers in the diagnosis of mast cell activation	7
Current strategies for phenotyping and managing asthma in preschool children	7
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	7
Editorial introductions	7
Role of the ocular surface microbiome in allergic eye diseases	7
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	7
Strengthening the case for intralymphatic immunotherapy	7
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	7
Food allergy: new therapeutic options open deeper questions	7
Exposome mapping in chronic respiratory diseases: the added value of digital technology	6
Precision medicine to personalize medicine in allergic airway disease	6
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	6
New causes of occupational allergic contact dermatitis	6
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	6
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	6
The role of macrolides in chronic rhinosinusitis and nasal polyps	6
Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	6
Giant cell arteritis and innovative treatments	6
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	6

Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity	6
Immunobiologicals and ocular surface disease	6
Occupational respiratory allergy to reactive dyes	6
Adverse effects of anti-cancer biologics on the ocular surface	6
Predictive models and applicability of artificial intelligence-based approaches in drug allergy	6
Interstitial lung diseases in inborn errors of immunity	6
Comparison of structural components and functional mechanisms within the skin vs. the conjunctival surface	5
Omalizumab is the Columbus egg for food allergies	5
New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis	5
Editorial introductions	5
New insights in mite immunotherapy – sublingual tablets	5
Editorial introductions	5
Assessment of receptor affinities of ophthalmic and systemic agents in dry eye disease	5
MicroCrystalline Tyrosine-adsorbed immunotherapy	4
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	4
Editorial introductions	4
Editorial introductions	4
Recent advances in the diagnosis and management of tree nut and seed allergy	4
Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma	4
Clinical outcomes of AIT in the elderly population	4
Endotypes of occupational asthma	4
The development of the DEFASE project	4
An update on patient reported outcomes in type 2 inflammation airway disease	4
How E-cigarettes and vaping can affect asthma in children and adolescents	4
Editorial introductions	4
New insights into the mechanisms of aspirin-exacerbated respiratory disease	4
Role of biologics in severe food allergy	4
The risk of anaphylaxis on holidays	4
Type-2-low severe asthma endotypes for new treatments: the new asthma frontier	4
Moderate asthma: burden, mechanisms and therapeutic perspectives	4
Editorial: Pharmacotherapy and evidence based medicine	4
Update on aspirin exacerbated respiratory disease with chronic rhinosinusitis	4
Neurostimulation for dry eye disease	4
Diagnosis, management and therapeutic options for eosinophilic esophagitis	4
Ocular surface disorders: office procedures for the allergist/clinical immunologist	4
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	4
New evidence in food allergies treatment	4
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	4
Editorial introductions	3
Editorial introductions	3
The evolution of cyclosporine treatments for treatment of ocular surface diseases	3
Long-term outcome of occupational asthma with different etiology	3
Advances in gene therapy for inborn errors of immunity	3
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker	3
Biologicals in IgE-mediated food allergy	3
STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders	3
Corneal complications of rheumatoid arthritis	3
Perioperative anaphylaxis: updates on pathophysiology	3
Integrative therapeutics for ocular surface disorders	3
Anaphylaxis: glimpse into the future, attention to the present	3
Update on the use of allergen challenge chambers in immunotherapy: clinical implications	3
Chronic urticaria: not only after COVID-19 vaccination	3
Psychosocial impact of ocular surface allergic inflammatory disorders	3
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency	3
Applying the new guidelines to asthma management in children	3
Management of food allergy based on oral food challenge	3
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	3
Genetic landscape of atopic dermatitis	3
Biologics and severe asthma in children	3
Predicting the course of asthma from childhood until early adulthood	3
Clinical outcomes of efficacy in food allergen immunotherapy trials	3
Editorial introductions	3
Biologics to treat anaphylaxis	3
Editorial introductions	3
Anaphylaxis in elderly people	3